Old Web
English
Sign In
Acemap
>
authorDetail
>
Bridget Riley-Gillis
Bridget Riley-Gillis
AbbVie
Oncology
Breast cancer
Internal medicine
Veliparib
Biomarker (medicine)
3
Papers
72
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Veliparib (V) monotherapy after progression on placebo (PL) + carboplatin/paclitaxel (CP) in patients with advanced HER2-negative gBRCA-associated breast cancer: Crossover outcomes and exploratory biomarker analyses in BROCADE3.
2020
Journal of Clinical Oncology
Shannon Puhalla
Véronique Diéras
Banu Arun
Bella Kaufman
Hans Wildiers
Hyo S. Han
Jean-Pierre M. Ayoub
Vered Stearns
Yuan Yuan
Teresa Helsten
Bridget Riley-Gillis
Erin Murphy
Madan Gopal Kundu
Meijing Wu
David Maag
Christine K. Ratajczak
Cyril Ramathal
Michael Friedlander
Show All
Source
Cite
Save
Citations (1)
Acquired Resistance to BET-PROTACs(Proteolysis Targeting Chimeras) Caused by Genomic Alterations in Core Components of E3 ligase Complexes
2019
Molecular Cancer Therapeutics
Lu Zhang
Bridget Riley-Gillis
Priyanka Vijay
Yu Shen
Show All
Source
Cite
Save
Citations (70)
1